Nonalcoholic fatty liver disease
Conditions
Interventions
low-dose group:vitamin C250mg
Dose group:vitamin C1000mg
High dose group:vitamin C2000mg
Sponsors
Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as nonalcoholic fatty liver disease; 2. Adults aged 18-60; 3. Patients who did not take any drugs or vitamin supplements within three months before admission; 4. Regular meals. Patients with stable body weight in the past three months had no excessive drinking or overeating in the past two weeks; 5. Patients who agree to participate in the trial and sign the informed consent; 6. Patients whose liver and kidney function indexes and ECG are within the normal range.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of vitamin C supplementation in the past 3 months; 2. Patients with viral hepatitis, drug hepatitis and other liver diseases; 3. Other patients with specific diseases that may cause hepatitis; 4. The alcohol consumption was more than 140 g / week for men and 70 g / week for women; 5. Patients with severe liver and kidney failure and organic diseases of lung and brain; 6. Patients with recent history of trauma, operation and infection; 7. Patients with malignant tumors and hematological diseases; 8. Patients who are not suitable to participate in the disease study of this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma vitamin C concentration;adiponectin; | — |
Countries
China
Contacts
Public ContactLuo Xiaoqin
Xi'an Jiaotong University
Outcome results
None listed